The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Distribution alliance in Australia and Dubai for leading providers of lighting equipment
Representing one of the leading providers of lighting fixtures regarding a strategic alliance with partners from Australia and Dubai for the more
Patent prosecution for drug discovery company
Represent an emerging drug discovery company with small and large molecule therapeutics with respect to patent prosecution and related counseling. more
Negotiation of long term lease and development agreement for an international hotel company
Represented an international hotel company in the negotiation of long term lease of condominium unit in multi-use high rise building on historic more
Strategic alliance negotiations between Internet hosting company and a leading telecommunications company
Represented Internet hosting company in negotiation of strategic alliance with a leading telecommunications company. more